DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Sundry Debtors | ₹2,731 Cr | ₹2,156 Cr | ₹1,793 Cr | ₹2,424 Cr | ₹1,677 Cr |
What is the latest Sundry Debtors ratio of DIVIS LABORATORIES ?
Year | Sundry Debtors |
---|---|
Mar2025 | ₹2,731 Cr |
Mar2024 | ₹2,156 Cr |
Mar2023 | ₹1,793 Cr |
Mar2022 | ₹2,424 Cr |
Mar2021 | ₹1,677 Cr |
How is Sundry Debtors of DIVIS LABORATORIES Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2025 | ₹2,731 Cr | 26.67 | |
Mar2024 | ₹2,156 Cr | 20.25 | |
Mar2023 | ₹1,793 Cr | -26.03 | |
Mar2022 | ₹2,424 Cr | 44.58 | |
Mar2021 | ₹1,677 Cr | - |
Compare Sundry Debtors of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹159,301.3 Cr | -2.7% | -2.2% | 17.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,718.0 Cr | 1% | -0.2% | -13.4% | Stock Analytics | |
CIPLA | ₹125,351.0 Cr | -1.7% | 4.1% | -5.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,267.0 Cr | 1% | 1.3% | 4.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,952.0 Cr | 2.5% | 7.7% | -6.7% | Stock Analytics | |
MANKIND PHARMA | ₹106,884.0 Cr | 1.2% | 1.9% | 4.4% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -2.7% |
-2.2% |
17.6% |
SENSEX | 1.2% |
0.7% |
-1.5% |
You may also like the below Video Courses